Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 23% ± 7% | |
lung | 8 studies | 25% ± 5% | |
kidney | 4 studies | 19% ± 3% | |
pancreas | 3 studies | 32% ± 10% | |
bone marrow | 3 studies | 19% ± 3% | |
eye | 3 studies | 21% ± 6% | |
lymph node | 3 studies | 22% ± 7% | |
brain | 3 studies | 27% ± 4% | |
liver | 3 studies | 33% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4942.22 | 2642 / 2642 | 100% | 210.96 | 705 / 705 |
esophagus | 100% | 3828.99 | 1445 / 1445 | 100% | 78.76 | 183 / 183 |
intestine | 100% | 3699.85 | 966 / 966 | 100% | 124.21 | 527 / 527 |
liver | 100% | 2064.33 | 226 / 226 | 100% | 127.77 | 406 / 406 |
lung | 100% | 3371.63 | 578 / 578 | 100% | 137.42 | 1155 / 1155 |
ovary | 100% | 3350.62 | 180 / 180 | 100% | 108.83 | 430 / 430 |
stomach | 100% | 2930.99 | 359 / 359 | 100% | 96.47 | 286 / 286 |
uterus | 100% | 3787.94 | 170 / 170 | 100% | 180.36 | 459 / 459 |
kidney | 100% | 3714.99 | 89 / 89 | 100% | 162.90 | 900 / 901 |
thymus | 100% | 3484.30 | 653 / 653 | 100% | 188.79 | 604 / 605 |
breast | 100% | 3903.92 | 459 / 459 | 100% | 190.30 | 1116 / 1118 |
bladder | 100% | 3632.43 | 21 / 21 | 100% | 141.93 | 503 / 504 |
prostate | 100% | 3248.22 | 245 / 245 | 100% | 136.98 | 501 / 502 |
skin | 100% | 4298.75 | 1809 / 1809 | 100% | 146.99 | 471 / 472 |
pancreas | 99% | 1609.54 | 324 / 328 | 100% | 151.95 | 178 / 178 |
adrenal gland | 100% | 3961.64 | 258 / 258 | 98% | 135.83 | 225 / 230 |
adipose | 100% | 3801.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4178.97 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 146.74 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 182.88 | 29 / 29 |
muscle | 100% | 4096.85 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4176.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 170.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.58 | 1 / 1 |
peripheral blood | 100% | 4560.37 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 2207.47 | 841 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ZMAT2 |
Protein name | Zinc finger matrin-type protein 2 Zinc finger matrin-type 2 |
Synonyms | |
Description | FUNCTION: Involved in pre-mRNA splicing as a component of the spliceosome. . |
Accessions | ENST00000506644.3 R4GMX9 ENST00000274712.8 ENST00000519913.6 R4GNG8 Q96NC0 |